TEMELIMAB
UNII T32CR1A69R

Substance Identification & Data

This profile provides standardized clinical and technical data for Temelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T32CR1A69R.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1393641-34-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

T32CR1A69R

CAS Registry Number

1393641-34-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TEMELIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C170386

National Cancer Institute reference terminology for clinical and research data.

INN ID

10830

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Temelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TEMELIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4, ANTI-(MULTIPLE SCLEROSIS-ASSOCIATED RETROVIRUS VIRAL ENVELOPE PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL GNBAC1 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GNBAC1 .KAPPA.-CHAIN, DIMER

TEMELIMAB [INN]

TEMELIMAB [WHO-DD]